Role of wild ruminants in the epidemiology of bluetongue virus serotypes 1, 4 and 8 in Spain
© García-Bocanegra et al; licensee BioMed Central Ltd. 2011
Received: 7 March 2011
Accepted: 23 July 2011
Published: 23 July 2011
Although the importance of wild ruminants as potential reservoirs of bluetongue virus (BTV) has been suggested, the role played by these species in the epidemiology of BT in Europe is still unclear. We carried out a serologic and virologic survey to assess the role of wild ruminants in the transmission and maintenance of BTV in Andalusia (southern Spain) between 2006 and 2010.
A total of 473 out of 1339 (35.3%) wild ruminants analyzed showed antibodies against BTV by both ELISA and serum neutralization test (SNT). The presence of neutralizing antibodies to BTV-1 and BTV-4 were detected in the four species analyzed (red deer, roe deer, fallow deer and mouflon), while seropositivity against BTV-8 was found in red deer, fallow deer and mouflon but not in roe deer. Statistically significant differences were found among species, ages and sampling regions. BTV RNA was detected in twenty-one out of 1013 wild ruminants (2.1%) tested. BTV-1 and BTV-4 RNA were confirmed in red deer and mouflon by specific rRT-PCR.
BTV-1 and BTV-4 seropositive and RNA positive wild ruminants, including juveniles and sub-adults, were detected years after the last outbreak was reported in livestock. In addition, between the 2008/2009 and the 2010/2011 hunting seasons, the seroprevalence against BTV-1, BTV-4 and BTV-8 increased in the majority of provinces, and these serotypes were detected in many areas where BTV outbreaks were not reported in domestic ruminants. The results indicate that wild ruminants seem to be implicated in the dissemination and persistence of BTV in Spain.
Bluetongue (BT) is a vector-borne disease caused by a group of viruses belonging to the genus Orbivirus, which is mainly transmitted between vertebrate hosts by biting midges of the genus Culicoides. To date, 24 distinct BT virus (BTV) serotypes have been identified; three of which were found in Andalusia (southern Spain) during the last decade. In October 2004, BTV-4 was detected in Cádiz Province (south-west Andalusia), and a total of 316 outbreaks were reported in livestock. The last BTV-4 outbreak was detected in October 2005, and the country was declared free of BTV-4 in March 2009 . However, in October 2010 a new BTV-4 outbreak was detected in Cádiz, and until December 2010 eight further outbreaks were reported.
In July 2007, a new BT epidemic, caused by BTV-1, affected southern Spain. BTV-1 causes clinical disease to both sheep and goats and 4446 outbreaks were detected from July 2007 through December 2008 in Andalusia. While no BTV-1 outbreaks were detected during 2009, two new cases were confirmed at the end of 2010 in the Jaén Province (northern Andalusia) . Furthermore, BTV-8 was detected in northern Spain in January 2008, and arrived in Andalusia in October 2008. Until March 2009, 23 BTV-8 outbreaks were reported, followed by a period without apparent cases. In November 2010, a new BTV-8 outbreak was confirmed.
A mandatory vaccination program in domestic ruminants against serotype 4 started in 2004 and was maintained until 2008, two years after the last outbreak was reported. In 2010 vaccination against BTV-4 was resumed in the southern provinces of Andalusia to prevent introduction from northern Africa . Since November 2006, animals have also been vaccinated against serotype 1, and since the end of 2008 also against BTV-8. Currently, BTV-1, BTV-4 and BTV-8 are endemic in Andalusia, and therefore the southern regions of Spain are considered restriction zones for these serotypes . A live attenuated vaccine against BTV-4 was used between 2004 and 2005. However, since 2006 the commercial vaccines against the three serotypes are inactivated vaccines .
A wide range of wild ruminant species in Europe have been affected by BTV [4–6]. In Spain, seropositivity to BTV was found in central and southern regions [7, 8]. In addition, clinically affected mouflons (Ovis aries) were reported in Andalusia [9, 10].
The distribution and density of wild ungulates in Spain have increased in recent decades and their populations usually share pastures with domestic ruminants . Although the role played by wild ruminant species in the epidemiology of BT in Europe is still unclear, the importance of these species as both potential reservoirs and sentinels of BTV has been suggested, especially in regions where livestock and wild ruminants share the same habitat [6, 10, 12–14]. In order to investigate the possible role of wild ruminants in the epidemiology of the bluetongue virus, a large-scale serologic and virologic survey was carried out in southern Spain from 2006 through 2010.
Materials and methods
Post-mortem examinations were carried out on 1446 randomly selected free-ranging wild ruminants shot during the hunting seasons (October-March) of the five study years. A total of 1396 blood samples were collected into sterile tubes without anticoagulant and centrifuged at 400 g for 15 min. Blood samples from 336 animals were also placed in sterile tubes containing EDTA for RT-PCR analysis. In addition, 759 spleen samples were collected during the necropsies. All samples were stored at -20°C until analysis. Species, location, age, sex and hunting season of each animal were recorded. The animals were classified into three age groups based on tooth replacement: juveniles (< 1 year old), sub-adults (between 1 and 2 years old) and adults (> 2 years old). Unfortunately, the ages of 327 animals and the sexes of 382 could not be recorded. Data on BTV outbreaks in domestic animals in Andalusia were obtained from the Spanish Ministry of Agriculture, Fisheries and Food .
The presence of antibodies against the VP7 protein of BTV was determined using a commercial double-antigen enzyme linked assay (ELISA; INGEZIM BTV DR 12.BTV.K0, INGENASA, Madrid, Spain) according to the manufacturer's recommendations. This ELISA has been used in previous surveys in wild ruminants [8, 15].
ELISA positive sera were then tested with the serum neutralization test (SNT) for BTV-1, BTV-4 and BTV-8 as previously described . Briefly, serum samples were inactivated at 56°C for 30 min prior to analysis. Sera were diluted (1:2 - 1:256) in MEM (Eagle's minimum essential medium) and mixed with 100 TCID50 (50% tissue culture infective doses) of each reference strain, BTV-1, BTV-4 and BTV-8. Plates were incubated for 1 h 30 min at 37°C. Finally, 100 μL of a Vero E6 cell suspension (1.5 × 104 cells/well) were added in cell growth media (MEM supplemented with 15% fetal calf serum, 300 μg L-glutamine/mL, 300 U penicillin/mL and 300 μg streptomycin/mL). The mixture was further incubated for 6 - 7 days at 37 μC until a cytopathic effect (CPE) was developed in control wells containing 100 TCID50 of virus and no serum. Only samples that showed neutralization (absence of CPE) at dilutions ≥1:4 were considered positive . Controls for cytotoxicity in the absence of virus were included for each sample at a dilution of 1:2. Seroprevalence to BTV was determined from samples positive by ELISA and SNT.
Blood and spleen samples were analyzed using a semi-quantitative real time reverse transcriptase-PCR (rRT-PCR) detecting a conserved region within segment 5 of the BTV genome . Serotype specific rRT-PCR was performed on BTV positive samples, according to the following methods: for BTV-1 ; for BTV-4 [Agüero, not published]; for BTV-8 . Field-isolated strains were used as positive controls for PCR amplification: BTV-1 (BTV-1 SPA/2007/01), BTV-4 (BTV-4 isolated in Cádiz in 2004) and BTV-8 (BTV-8 BEL/2006/01).
Association between explanatory variables (species, age, region, sex and hunting season) and BTV seropositivity was tested in three steps. Firstly, a bivariate chi-square test was performed to obtain an indication of the relevance of the explanatory variables in the risk of an animal being seropositive. Secondly, factors showing a p-value < 0.25 were further scrutinized for associations using the Pearson correlation coefficient (r) to avoid collinearity problems. If r was larger than 0.4, the variable more clearly linked to BTV infection was retained. The third step involved a multiple logistic-regression model as described by Hosmer and Lemeshow . This was performed using a non-automatic backward selection of variables. Biologically plausible confounding factors were tested using Mantel-Haenszel analysis and confounding was considered to be potentially significant if odds ratio (OR) shifted appreciably. Changes in the OR greater than 30% were considered indicative of confounding. Potential two-way interactions between the variables were tested for significance in the model. The model was re-run until all the remaining variables presented statistically significant values (likelihood-ratio Wald test, P < 0.05), and a potential causal relationship with the response variable existed. Statistical analyses were performed using SPSS 15.0 (Statistical Package for Social Sciences (SPSS) Inc., Chicago, IL, USA).
A total of 639 out of 1396 wild ruminants (45.8%) analyzed showed antibodies against BTV by ELISA. Fifty-seven serum samples positive by ELISA could not be analyzed by SNT due to cytotoxicity, and 109 samples were positive by ELISA but negative by SNT. Therefore, a total of 473 out of 1339 wild ruminants (35.3%; CI95%: 32.7-37.9) analyzed showed antibodies against BTV by both ELISA and SNT. Seroprevalences to BTV serotypes were 25.6% to BTV-1 (343/1339; CI95%: 23.3-27.9), 21.6% to BTV-4 (289/1339; CI95%: 19.4-23.8) and 3.4% to BTV-8 (45/1339; CI95%: 2.4-4-4).
Frequency of antibodies against BTV in wild ruminants.
No. Positive (%)
Logistic regression analysis of potential risk factors associated with BTV seropositivity.
Distribution of BTV serotypes by hunting season and province.
BTV RNA was detected in twenty-one out of 1013 wild ruminants analyzed (2.1%; CI95%: 1.2-2.6). The threshold cycle (Ct) RT-PCR values ranged between 30.1 and 38.1 (median = 35.5). Nineteen red deer and one mouflon were positive by BTV-1 specific rRT-PCR. BTV-1 RNA-positive results were found in the 2006/2007, the 2009/2010 and the 2010/2011 hunting seasons. One spleen sample from an adult deer sampled in the 2010/2011 hunting season was positive by BTV-4 specific rRT-PCR. No pathological lesions compatible with BT were observed in any of the BTV RNA-positive animals.
Our findings confirm that wild ruminants were actively exposed to BTV in the study area. A large number of the samples tested were positive by ELISA but negative by SNT. The differences between the tests, likely reflect that ELISA and SNT measure distinct antibody populations. The ELISA used in the present study detects both IgM and IgG antibodies to BTV, and it has been proven to be highly sensitive and specific in livestock . Even though the quality of sera may also influence the results of both tests, it is particularly important for SNT. In fact, a high number of samples positive by ELISA could not be analyzed by SNT due to cytotoxicity. BTV seroprevalence was determined only from samples positive by both ELISA and SNT and therefore could have been underestimated.
To our knowledge, this is the first study on BTV serotypes in different wild ruminant species. The seroprevalence levels indicate widespread circulation of BTV in red deer, fallow deer and mouflon, which is in agreement with what was previously reported [6–8]. The results support the idea that sero-surveillance on these species would be useful to detect virus circulation, especially in areas where a vaccination program has been implemented in livestock [9, 10]. Furthermore, the low seropositivity detected in roe deer is in agreement with previous studies [7, 12, 22], suggesting that it is not a relevant species in the dissemination of BTV. Differences among species might be related to the natural resistance of the hosts, population densities, geographical distribution, sampling period or management factors.
The higher seroprevalence in adult animals was probably due to a greater exposure of this age group to the virus over time [8, 10, 12]. Interestingly, seropositivity was found in young animals (juveniles and sub-adults) sampled long after any previous outbreak in domestic ruminants. This was particularly clear in the case of BTV-4: even though the last outbreak in domestic ruminants was reported in October 2005, juveniles and sub-adults of the different wild ruminant species analyzed presented antibodies against BTV-4 between the 2008/2009 and the 2010/2011 hunting seasons in all the provinces where outbreaks had been reported in livestock. Similar findings were observed for BTV-1 and BTV-8, and evidence the ability of BTV to circulate despite no cases reported in domestic ruminants. Whether that circulation indicates the maintenance of BTV within the wild ruminant population despite vaccination of domestic ruminants, or is the consequence of repeated introductions of the virus, merits further studies.
No antibodies against BTV-4, BTV-1 or BTV-8 were detected in wild ruminants sampled prior to the detection of the first outbreak of each serotype in livestock. Between the 2008/2009 and the 2010/2011 hunting seasons, seroprevalence against the different serotypes increased in the majority of areas, even when the same species and ages were compared. These findings could indicate the persistence of antibodies against BTV for very long periods or, more likely, a longer BTV maintenance and circulation in wild ruminants compared to livestock. The lower seropositivity against BTV-8 (3.4%) was not unexpected taking into account that only 24 outbreaks had been reported in livestock in the study area .
The risk of being a seropositive animal was 2.3 and 3.9 times higher in the western and central regions, respectively, as compared to the eastern, which is in accordance with the geographical distribution of BTV observed in domestic ruminants (Figure 2). Vector density, host density and environmental factors are possibly implicated in the spatial distribution of BTV [23, 24]. However, BTV-1, BTV-4 and BTV-8 seropositive animals were detected in regions where these serotypes were not reported in livestock. This was particularly evident for BTV-8 (Figure 2) and confirms a different spatial distribution of BTV in wild ruminants as compared to livestock [8, 15].
The presence of BTV-1 and BTV-4 RNA in red deer and mouflon confirms the susceptibility of these species to BTV infection [9, 10]. In addition, the low cycles (Ct) RT-PCR values obtained in 12 animals (Ct lower than 35) support the potential reservoir role of these species. Three of BTV-1 RNA positive wild ruminants were found in November 2009, even though the last BTV-1 outbreak in livestock was reported in December 2008. One of these BTV-1 RNA positive animals showed no antibodies by ELISA or SNT, which could suggest a fresh infection in this animal [12, 13]. Furthermore, BTV-1 RNA positive wild ruminants sampled in the 2010/2011 hunting season were detected in locations different from those where the last BTV-1 outbreak was reported in livestock . The BTV-4 RNA positive animal was detected on November 2010, one month after this serotype was first detected on a sentinel farm located at 60 km distance.
Vaccination has been suggested as one of the most important control measures for BT . In this sense, the limited number of cases reported in livestock despite the circulation observed in wild ruminants suggests that vaccination seems to be effective to prevent the clinical disease. However, to prevent outbreaks in livestock, the vaccination of the domestic population would have to be maintained until virus circulation within the wild ruminant population has ceased.
Our results confirm that wild ruminant populations from southern Spain were exposed to BTV-1, BTV4 and BTV-8. The high seroprevalence to BTV-1 and BTV-4 found in the present study, the detection of both BTV seropositive and RNA positive animals, including juvenile animals, years after the last outbreak was reported in livestock, and the presence of the different BTV serotypes in areas where BTV outbreaks had never been reported in domestic ruminants, indicate that wild ruminants seem to be implicated in the dissemination and persistence of BTV, and probably play a significant role as reservoirs for BTV.
We would like to thank everyone involved in the Epidemiological Monitoring Program in Wildlife of the Regional Government of Andalusia for providing the samples. We are also grateful to Julio J Pérez for his technical assistance. This work was supported by INIA Grant FAU2008-00019-C03-01 and the Regional Government of Andalusia.
- Red de Alerta Sanitaria Veterinaria (RASVE), 2009. Ministerio de Medio Ambiente Medio Rural y Marino. Accessed November 5, 2009, [http://rasve.mapa.es/Publica/Noticias/Ficheros/Informe%20libre%20serotipo%204%20final.pdf]
- Red de Alerta Sanitaria Veterinaria (RASVE), 2010. Ministerio de Medio Ambiente Medio Rural y Marino. Accessed December 18, 2010, [http://rasve.mapa.es/RASVE_2005/Publica/RASVE_NET_2005/Rasve.Presentacion/Modulo.Focos/Consultar_Focos.aspx]
- Red de Alerta Sanitaria Veterinaria (RASVE), 2011. Ministerio de Medio Ambiente Medio Rural y Marino. Accessed April 21, 2011, [http://rasve.mapa.es/Publica/Programas/NORMATIVA%20Y%20PROGRAMAS/PROGRAMAS/2011/LENGUA%20AZUL/PROGRAMA%20LENGUA%20AZUL%202011.PDF]
- De Curtis M, Bartolini C, Canonico C, Duranti A, Leoni F, Mancini P, Moscatelli F, Rocchegiani E, Gavaudan S: Serological monitoring of bluetongue virus in wild ruminants of the Pesaro-Urbino district (Italy). Webzine Sanita Pubblica Veterinaria. 2006, 40: 3-
- Linden A, Mousset B, Gregoire F, Hanrez D, Vandenbussche F, Vandemeulebroucke E, Vanbinst T, Verheyden B, de Clerck K: Bluetongue virus antibodies in wild red deer in southern Belgium. Vet Rec. 2008, 162: 459-View ArticlePubMed
- Falconi C, López-Olvera JR, Gortázar C: BTV infection in wild ruminants, with emphasis on red deer: a review. Vet Microbiol. 2011, 151: 209-219. 10.1016/j.vetmic.2011.02.011.View ArticlePubMed
- Ruíz-Fons F, Reyes-García AR, Alcaide V, Gortázar C: Spatial and temporal evolution of bluetongue virus in wild ruminants, Spain. Emerg Infect Dis. 2008, 14: 951-953. 10.3201/eid1406.071586.PubMed CentralView ArticlePubMed
- García I, Napp S, Casal J, Perea A, Allepuz A, Alba A, Carbonero A, Arenas A: Bluetongue epidemiology in wild ruminants from southern Spain. Eur J Wildl Res. 2009, 55: 173-178. 10.1007/s10344-008-0231-6.View Article
- Fernández-Pacheco P, Fernández-Pinero J, Agüero M, Jiménez-Clavero MA: Bluetongue virus serotype 1 in wild mouflons in Spain. Vet Rec. 2008, 162: 659-660. 10.1136/vr.162.20.659.View ArticlePubMed
- Rodríguez-Sánchez B, Sánchez-Cordón PJ, Molina V, Risalde MA, de Diego AC, Gómez-Villamandos JC, Sánchez-Vizcaíno JM: Detection of bluetongue serotype 4 in mouflons (Ovis aries musimon) from Spain. Vet Microbiol. 2010, 141: 164-167. 10.1016/j.vetmic.2009.08.003.View ArticlePubMed
- Gortázar C, Acevedo P, Ruiz-Fons F, Vicente J: Disease risk and overabundance of game species. Eur J Wildl Res. 2010, 52: 81-87.View Article
- Linden A, Gregoire F, Nahayo A, Hanrez D, Mousset B, Massart L, De Leeuw I, Vandemeulebroucke E, Vandenbussche F, De Clercq K: Bluetongue virus in wild deer, Belgium, 2005-2008. Emerg Infect Dis. 2010, 16: 833-836.PubMed CentralView ArticlePubMed
- López-Olvera JR, Falconi C, Fernández-Pacheco P, Fernández-Pinero J, Sánchez MA, Palma A, Herruzo I, Vicente J, Jiménez-Clavero MA, Arias M, Sánchez-Vizcaíno JM, Gortázar C: Experimental infection of European red deer (Cervus elaphus) with bluetongue virus serotypes 1 and 8. Vet Microbiol. 2010, 145: 148-152. 10.1016/j.vetmic.2010.03.012.View ArticlePubMed
- Durand B, Zanella G, Biteau-Coroller F, Locatelli C, Baurier F, Simon C, Le Dréan E, Delaval J, Prengère E, Beauté V, Guis H: Anatomy of bluetongue virus serotype 8 epizootic wave, France, 2007-2008. Emerg Infect Dis. 2010, 16: 1861-1868.PubMed CentralView ArticlePubMed
- Lorca-Oró C, Pujols J, Arenas A, Gómez-Guillamón F, Zorrilla I, Domingo M, Arenas-Montés A, Ruano MJ, García-Bocanegra I: Epidemiological surveillance of bluetongue virus serotypes 1, 4 and 8 in Spanish ibex (Capra pyrenaica hispanica) in southern Spain. Vet Microbiol. 2010, 149 (1-2): 230-235.View ArticlePubMed
- World Organization for Animal Health (OIE). Bluetongue and Epizootic Haemorrhagic Disease. 2009, Chapter 2.1.3: [http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.03_BLUETONGUE.pdf]
- Toussaint JF, Sailleau C, Breard E, Zientara S, De Clercq K: Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods. 2007, 140: 115-123. 10.1016/j.jviromet.2006.11.007.View ArticlePubMed
- Agüero M, Jiménez-Clavero MA, El Harrak M, Gómez-Tejedor C: Real time RT-PCR method for specific detection of bluetongue virus serotype 1 strain Algeria 2006. Detection of the first BTV-1 outbreak in Spain. Abstract of the Bluetongue Satellite Symposium "Bluetongue in Europe, back to the future"; Brescia, Italy. 2008, 59-
- Hoffmann B, Eschbaumer M, Beer M: Real-time quantitative reverse transcription-PCR assays specifically detecting bluetongue virus serotypes 1, 6, and 8. J Clin Microbiol. 2009, 47: 2992-2994. 10.1128/JCM.00599-09.PubMed CentralView ArticlePubMed
- Hosmer DW, Lemeshow S: Applied logistic regression. 1989, Johns Wiley & Sons, New York, USA
- Niedbalski W: Comparison of four ELISAs for the detection of antibodies against bluetongue virus. Medycyna Wet. 2010, 66: 106-108.
- Boadella M, Carta T, Oleaga A, Pajares G, Muñoz M, Gortázar C: Serosurvey for selected pathogens in Iberian roe deer. BMC Vet Res. 2010, 6: 51-10.1186/1746-6148-6-51.PubMed CentralView ArticlePubMed
- Allepuz A, García-Bocanegra I, Napp S, Casal J, Arenas A, Saez M, González MA: Monitoring bluetongue disease (BTV-1) epidemic in southern Spain during 2007. Prev Vet Med. 2010, 96: 263-271. 10.1016/j.prevetmed.2010.06.005.View ArticlePubMed
- Acevedo P, Ruiz-Fons F, Estrada R, Márquez AL, Miranda MA, Gortázar C, Lucientes J: A broad assessment of factors determining Culicoides imicola abundance: modelling the present and forecasting its future in climate change scenarios. PLoS One. 2010, 5: e14236-10.1371/journal.pone.0014236.PubMed CentralView ArticlePubMed
- Bhanuprakash V, Indrani BK, Hosamani M, Balamurugan V, Singh RK: Bluetongue vaccines: the past, present and future. Expert Rev Vaccines. 2009, 8: 191-204. 10.1586/147605184.108.40.206.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.